Edgewise Therapeutics(US:EWTX) ZACKS·2025-09-02 14:55Core Viewpoint - Edgewise Therapeutics, Inc. (EWTX) shows significant upside potential with a mean price target of $39.17, indicating a 173% increase from its last trading price of $14.35 [1][11]. Price Targets and Analyst Consensus - The average price target for EWTX is based on 12 short-term estimates, ranging from a low of $14.00 to a high of $51.00, with a standard deviation of $12.96, suggesting variability in analyst predictions [2][9]. - The lowest estimate indicates a potential decline of 2.4%, while the highest suggests a 255.4% upside [2]. - A low standard deviation among price targets indicates strong agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about EWTX's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11]. - The Zacks Consensus Estimate for the current year has risen by 9.1% over the past month, with eight estimates increasing and no negative revisions [12]. - EWTX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, as empirical research indicates that they rarely predict actual stock price movements accurately [7][10]. - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8].